ArticleEuropean heart journal. Quality of care & clinical outcomes2026
Characteristics, clinical management and outcomes of patients with acute myocardial infarction enrolled or not enrolled in a quality registry.
Article in European heart journal. Quality of care & clinical outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
aimsStructured care through enrollment and data collection in quality registries may lead to better care and improved outcomes. We investigated differences in admission characteristics, clinical management and outcomes between patients with acute myocardial infarction enrolled vs. non-enrolled in the SWEDEHEART quality registry. METHODS AND
resultsWe linked health records from all hospitalisations (n = 47 342) due to a first or recurrent myocardial infarction between 2006 and 2021 in the region of Stockholm, Sweden, to SWEDEHEART. We compared non-enrolled vs. enrolled patients in terms of characteristics, invasive procedures, use of and adherence to guideline-recommended medications, in-hospital mortality, and clinical outcomes after discharge. Non-enrolled participants (n = 6 113, 13%) were older, had more chronic kidney disease and other comorbidities. They underwent fewer coronary angiographies and fewer coronary interventions. Non-enrolled participants were less likely to initiate aspirin (HR 0.88, 95% CI 0.84-0.91), beta-blockers (HR 0.87, CI 0.84-0.90), renin-angiotensin system inhibitors (HR 0.73, CI 0.69-0.76), and statins (HR 0.59, CI 0.56- 0.61). They were also less likely to adhere to treatments, in part explained by their comorbid profile. Even after extensive adjustments, non-enrolled patients had higher in-hospital and long-term mortality (HR 1.15, 95% CI 1.09-1.21), and more reinfarction/stroke (HR 1.16, 95% CI 1.08-1.26) than enrolled patients.
conclusionPatients non-enrolled in SWEDEHEART received less evidence-based care and had worse short- and long-term outcomes. This study identifies a non-negligible population in need of better care and provides support for the value of structured care models in improving patient outcomes through closer monitoring and better treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.